Innovation Meets Investment: Flomark Ltd, a trailblazing startup based in Chesham, has successfully secured a substantial £300,000 investment to reshape fluid management in healthcare. The funding comes from two prominent sources: a generous £150,000 from the British Design Fund (BDF) and another £150,000 from the Imperial College Enterprise Fund (ICEF). This financial backing signifies a strong vote of confidence from key investors, paving the way for the development of Flomark's pioneering solutions aimed at enhancing patient safety during intravenous (IV) therapy.
Flomark's mission is clear: to transform the monitoring of fluid balance in healthcare settings.
Traditional methods often leave nurses counting the drops from an IV drip, leading to inaccuracies that can jeopardize patient care. Thanks to Flomark’s innovative technology, a sterile single-use flow meter with a simple visual indicator, clinicians can now effortlessly gauge how quickly fluids are administered to patients. A little red ball provides an instant reading of millilitres per hour, significantly minimizing the chance of complications such as fluid overload or acute kidney injury, ultimately ensuring more accurate and responsive patient care.
This breakthrough device not only streamlines nurses' workflows but also equips doctors with reliable data necessary for making informed decisions. The investment secured from BDF and ICEF will catalyze Flomark’s plans to launch its flagship product later this year and expand its pipeline of advanced healthcare solutions. Damon Bonser, CEO of the British Design Fund, highlighted the company's commitment to improving patient outcomes, expressing excitement about supporting Flomark in its journey to revolutionize healthcare delivery. For founders and investors alike, Flomark represents an exciting opportunity in the intersection of technology and healthcare, poised for impactful growth in this vital sector.
Click here for a full list of 6,908+ startup investors in the UK